Cost Of Wasted Eye Drops Counts As Harm, 3rd Circ. Told

By Steven Trader (July 27, 2016, 3:03 PM EDT) -- Patients accusing Merck and other drugmakers of boosting prescription eye drop sales by using bottles that dispensed higher than necessary doses have told the Third Circuit their class claims should be revived because the money lost from wasted medicine is a concrete injury....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!